Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Pirfenidone Tablet bulk supplier for pharma manufacturers

Pirfenidone Tablet 267 mg , 801 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 267 mg , 801 mg

Reference Brands: Esbriet(US & EU)

Category: Respiratory Disorder

Pirfenidone is an oral antifibrotic medication used to treat idiopathic pulmonary fibrosis (IPF). It slows lung scarring, improves lung function, and reduces inflammation. Marketed as Esbriet in the US and EU, it’s taken three times daily. Common side effects include nausea, rash, and liver enzyme changes.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Pirfenidone is an FDA- and EMA-approved oral antifibrotic drug used to treat idiopathic pulmonary fibrosis (IPF)—a chronic lung disease marked by progressive scarring of lung tissue. Marketed under the brand name Esbriet, pirfenidone helps slow lung function decline, reduce inflammation, and limit fibrosis by inhibiting pro-fibrotic cytokines like TGF-β. Available in 267 mg and 801 mg tablet strengths, it is usually taken three times daily with food. Pirfenidone improves quality of life and delays disease progression in IPF patients. Common side effects include nausea, rash, and photosensitivity. Regular liver monitoring is advised during treatment.

Pirfenidone Tablet — third party manufacturing & bulk supply

Pirfenidone Tablet 267 mg , 801 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Pirfenidone Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Pirfenidone Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Pirfenidone Tablet →
Back to Listing

Frequently Asked Questions

Pirfenidone is used to treat idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung disease. It helps slow the decline in lung function by reducing fibrosis and inflammation in lung tissue.

Pirfenidone is a small-molecule antifibrotic and anti-inflammatory agent. Its chemical name is 5-methyl-1-phenyl-2-(1H)-pyridone.

Pirfenidone is marketed under the trade name Esbriet in the USA, EU, and UK. Generic pirfenidone is also available in several EU countries under different brand names.

Pirfenidone was originally developed and is marketed by Roche under the brand name Esbriet. Generic versions are manufactured by multiple pharmaceutical companies.

The generic name is Pirfenidone.

The brand name is Esbriet. Generic brands are also available depending on the region.

Pirfenidone is manufactured in various countries including the USA and EU member states by Roche and approved generic manufacturers.

Related Products

Glycopyrrolate And Indacaterol

Strength:
27.5 mcg + 15.6 mcg or 85 mcg + 43 mcg

Form: Subcutaneous injection

Reference Brands: Utibron Neohaler(US), Ultibro Breezhaler(EU)

View Details
Terbutaline Sulfate

Strength:
Tab: 2.5 mg, 5 mg; Inj: 1 mg/ml; Inhale: 0.25 mg per inhalation

Form: Tablet, Injection & inhalation

Reference Brands: Brethine® (US) & Bricanyl®(EU)

View Details
Poractant Alfa

Strength:
80 mg/mL

Form: Intratracheal suspension

Reference Brands: Curosurf(Eu & US)

View Details
Acetylcysteine Oral Solution

Strength:
10% (100 mg/mL), 20% (200 mg/mL)

Form: Oral Solution

Reference Brands: Mucomyst(US); Fluimucil(EU)

View Details
Doxofylline Syrup

Strength:
100 mg/5 ml, 200 mg/5 ml,

Form: Oral Syrup

Reference Brands: Doxolin (India), Doxofyl (India/LATAM)

View Details
Isoniazid Syrup

Strength:
50 mg

Form: Oral Syrup

Reference Brands: Generic formulations marketed under different names

View Details
Bromhexine Hcl / Phenylephrine Hcl Tablet

Strength:
8mg +5mg

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details
Dextromethorphan Hbr + Bromhexine Hcl + Guaiphenesin + Phenylepherine Hcl + Cpm Tablet

Strength:
15mg + 8mg + 100mg + 5mg + 4mg

Form: Tablets / Oral suspension

Reference Brands: Kufrid DMR (India), Bromhist-PDX (USA), Benylin (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.